Cagrilintide
Reported Onset
2–4 weeks
Primary Use
Appetite control and weight management, especially synergistic with GLP-1 agonists.
Dose
0.3mg - 2.4mg
Frequency
Weekly
AOD-9604
Reported Onset
2–4 weeks
Primary Use
Targeted fat metabolism and body composition improvement without GH-related side effects.
Dose
300mcg - 500mcg
Frequency
Daily (fasted)
Community Verdict
Two modern weight loss peptides with different mechanisms. The community generally selects between Cagrilintide and AOD-9604 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for Cagrilintide or AOD-9604 at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified